Clinical Trial Update: HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions [Phase 4]

View source ↗

Summary

Phase 4 trial investigating an HPV vaccine therapy aimed at interrupting progression in high-grade anal canal intraepithelial neoplasia and high-grade vulvar sq…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Anal Canal Intraepithelial Neoplasia
• High-grade Vulvar Squamous Intraepithelial Lesion

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: High Grade Anal Canal Intraepithelial Neoplasia, High Grade Vulvar Squamous Intraepithelial Lesion | Phase 4 | Status: TERMINATED | Results posted: 2024-02-28